Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Neurological Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114716449B reveals a scalable synthesis route for Huperzine A intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced patent-based synthesis of Tetrabenazine intermediate offering high purity and yield. Reliable supply chain solutions for API manufacturing cost reduction.
Novel Cu/Ir synergistic catalysis for stereo-diverse tetrahydro-γ-carbolines. High yield, mild conditions, scalable pharmaceutical intermediate manufacturing.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN100540519C reveals a safer PTC-catalyzed route for 3,4-dimethoxyphenylacetaldehyde. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Patent CN111303013B reveals a mild DSC-mediated route for Pimaserin. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN101674835A reveals a streamlined synthesis for Galantamine intermediate C2, offering significant cost reduction and improved purity for API manufacturing supply chains.
Patent CN102399166B enables high-purity THPBs synthesis. Reduces cost and improves supply chain reliability for neurological drug intermediates.
Patent CN104726513B details high-yield enzymatic Levodopa production. Offers cost reduction in pharmaceutical manufacturing and scalable supply chain solutions for global buyers.
Patent CN1314684C details a novel Tiagabine synthesis route avoiding expensive organometallics, offering cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.